The Outcome of People Screened For Hepatitis B, in a Community-Based Setting in Ouagadougou, Burkina, 2018-2020

Results: The prevalence of hepatitis B was 11.94%. At 6 months, only 2 patients were cured; only 54.02% were followed up, of which 14.89% were under treatment. At 12 months, 28.74% of patients followed up had stopped the follow-up; two patients had progressed to liver cirrhosis. At 18 months, only 18.09% of patients had benefited from regular follow-up since screening; and 73.59% of those who tested negative had been vaccinated. The reasons for stopping or not seeking follow-up were financial constraints and not finding the need for follow-up.